Transforming Medical Affairs in China

Rethinking the role and effectiveness of the Medical Affairs function has become an urgent priority for pharmaceutical companies in China. As China’s rapidly changing market landscape drives more companies to develop differentiated value propositions in response to physician, patient and payer demands, Medical Affairs is rapidly emerging as an integral component of strategy.  Our recent report"Transforming Medical Affairs in China" presents our perspective on these challenges and how they can be successfully overcome.